Research Article
Pentraxin 3 Levels in Young Women with and without Polycystic Ovary Syndrome (PCOS) in relation to the Nutritional Status and Systemic Inflammation
Table 1
Baseline characteristics and comparison between PCOS and non-PCOS group.
| | PCOS (N = 99) | Non-PCOS (N = 60) | |
| | Age (years) | 26.9 ± 5.8 | 26.6 ± 5.0 | 0.72 | | Body mass (kg) | 90.7 ± 25.9 | 73.9 ± 15.7 | <0.001 | | BMI (kg/m2) | 34.4 (27.1–39.8) | 26.7 (21.2–32.1) | <0.001 | | Fat mass percentage | 42.8 ± 10.0 | 36.1 ± 9.0 | <0.001 | | Fat mass (kg) | 43.6 (27.0–52.7) | 27.1 (15.5–37.2) | <0.001 | | Waist circumference (cm) | 96.5 ± 19.8 | 86.2 ± 14.3 | <0.001 | | Total cholesterol (mg/dL) | 186.3 ± 30.6 | 175.6 ± 33.5 | <0.05 | | LDL cholesterol (mg/dL) | 98.1 ± 25.4 | 93.4 ± 27.7 | 0.86 | | HDL cholesterol (mg/dL) | 39.2 ± 14.5 | 51.1 ± 15.9 | <0.001 | | Triglycerides (mg/dL) | 115.0 (85.0–181.0) | 69.0 (56.0–105.0) | <0.001 | | Glucose (mg/dL) | 91.0 (84.0–97.0) | 90.0 (84.0–97.5) | 0.90 | | Insulin (μIU/ml) | 16.59 (10.48–25.51) | 7.23 (4.66–9.57) | <0.001 | | HOMA-IR | 3.63 (2.34–5.67) | 1.61 (0.98–2.25) | <0.001 | | FAI | 1.06 (0.43–1.91) | 0.37 (0.19–0.81) | <0.001 | | Estradiol (pg/mL) | 98.7 (64.1–195.7) | 234.0 (162.5–344.0) | <0.001 | | 17-OH-progesterone (ng/mL) | 1.27 (0.85–1.80) | 1.51 (1.08–2.05) | 0.06 | | SHBG (nmol/L) | 45.7 ± 30.6 | 80.3 ± 49.0 | <0.001 | | TNF- (pg/mL) | 0.97 (0.57–1.85) | 0.72 (0.56–0.99) | <0.001 | | IL-6 (pg/mL) | 1.61 (0.82–2.89) | 0.73 (0.45–1.28) | <0.001 | | MCP-1 (pg/mL) | 272.0 ± 151.6 | 245.0 ± 102.8 | 0.18 | | PTX3 (ng/mL) | 3.4 (2.1–6.9) | 1.4 (1.1–1.9) | <0.001 |
|
|
